1329 related articles for article (PubMed ID: 18636198)
21. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
24. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer.
Oshima T; Takenoshita S; Akaike M; Kunisaki C; Fujii S; Nozaki A; Numata K; Shiozawa M; Rino Y; Tanaka K; Masuda M; Imada T
Oncol Rep; 2011 May; 25(5):1439-46. PubMed ID: 21380491
[TBL] [Abstract][Full Text] [Related]
25. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
26. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
Zhang FR; He XB; Yang YH; Xie W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
[TBL] [Abstract][Full Text] [Related]
27. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Mimori K; Fukagawa T; Kosaka Y; Ishikawa K; Iwatsuki M; Yokobori T; Hirasaki S; Takatsuno Y; Sakashita H; Ishii H; Sasako M; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2934-42. PubMed ID: 18661187
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
[TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
Chong KY; Subramanian A; Mokbel K; Sharma AK
J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
[TBL] [Abstract][Full Text] [Related]
30. The insulin-like growth factor type 1 receptor and colorectal neoplasia: insights into invasion.
Allison AS; McIntyre MA; McArdle C; Habib FK
Hum Pathol; 2007 Nov; 38(11):1590-602. PubMed ID: 17651787
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor type-1 receptor down-regulation associated with dwarfism in Holstein calves.
Blum JW; Elsasser TH; Greger DL; Wittenberg S; de Vries F; Distl O
Domest Anim Endocrinol; 2007 Oct; 33(3):245-68. PubMed ID: 16829014
[TBL] [Abstract][Full Text] [Related]
32. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
33. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.
Huang CS; Fan YE; Lin CY; Hu ML
J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
Furukawa M; Raffeld M; Mateo C; Sakamoto A; Moody TW; Ito T; Venzon DJ; Serrano J; Jensen RT
Clin Cancer Res; 2005 May; 11(9):3233-42. PubMed ID: 15867218
[TBL] [Abstract][Full Text] [Related]
35. Relation of MT1-MMP gene expression to outcomes in colorectal cancer.
Kanazawa A; Oshima T; Yoshihara K; Tamura S; Yamada T; Inagaki D; Sato T; Yamamoto N; Shiozawa M; Morinaga S; Akaike M; Kunisaki C; Tanaka K; Masuda M; Imada T
J Surg Oncol; 2010 Nov; 102(6):571-5. PubMed ID: 20721961
[TBL] [Abstract][Full Text] [Related]
36. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
[TBL] [Abstract][Full Text] [Related]
37. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
Sun HZ; Wu SF; Tu ZH
Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
[TBL] [Abstract][Full Text] [Related]
38. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
Weng CJ; Hsieh YH; Tsai CM; Chu YH; Ueng KC; Liu YF; Yeh YH; Su SC; Chen YC; Chen MK; Yang SF
Ann Surg Oncol; 2010 Jul; 17(7):1808-15. PubMed ID: 20119675
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk.
Voskuil DW; Bosma A; Vrieling A; Rookus MA; van 't Veer LJ
Breast Cancer Res Treat; 2004 Apr; 84(3):225-33. PubMed ID: 15026620
[TBL] [Abstract][Full Text] [Related]
40. Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype.
Xie Y; Skytting B; Nilsson G; Brodin B; Larsson O
Cancer Res; 1999 Aug; 59(15):3588-91. PubMed ID: 10446966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]